Market LIVE
Published markets; coverage varies by country
Product profile · United States

SYFOVRE

 ·  Patent Litigation & Settlement History ↓

IngredientPEGCETACOPLAN
Application typeNDA
Application217171
Product001
Dosage formSOLUTION
RouteINTRAVITREAL
Strength15MG/0.1ML (15MG/0.1ML)
Approval date2023-02-17
Marketing statusPrescription
Status event—
ApplicantAPELLIS PHARMS
Product source

Current GenericRadar decision

Year2036
SelectionDEEP_REVIEW
ReviewFINAL
Anchor typePATENT
Anchor date2036-10-07
Patent anchor2036-10-07
Exclusivity anchor2026-05-14
Protection date2038-12-14
First Final ANDA—
Status event—

GNR judgment: DEEP_REVIEW. Reference year: 2036. Anchor type: PATENT. Patent anchor: 2036-10-07. Exclusivity anchor: 2026-05-14. Anchor date: 2036-10-07. Patent tail: yes. Exclusivity tail: no. Review status: FINAL. Historical detailed rationale is retained in the evidence snapshot; this is a structured English summary, not a literal translation.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
90560762026-10-25U U-3540NYU
English description not available.
———
90560762026-10-25ORANGE_BOOK U-3540NYU
English description not available.
———
81685842027-04-07U U-3540NYU
English description not available.
———
81685842027-04-07U U-3542NYU
English description not available.
———
81685842027-04-07ORANGE_BOOK U-3540;U-3542NYU
English description not available.
———
91693072027-11-18DS/U U-3541YNTRUE_DS
English description not available.
———
91693072027-11-18ORANGE_BOOK U-3541YNTRUE_DS
English description not available.
———
78883232027-12-04DS —YNTRUE_DS
English description not available.
———
78883232027-12-04ORANGE_BOOK —YNTRUE_DS
English description not available.
———
79895892027-12-04DS —YNTRUE_DS
English description not available.
———
79895892027-12-04ORANGE_BOOK —YNTRUE_DS
English description not available.
———
116614412033-01-13DS/U U-3540NYU
English description not available.
———
116614412033-01-13ORANGE_BOOK U-3540NYU
English description not available.
———
101251712033-08-02DS —YNTRUE_DS
English description not available.
———
101251712033-08-02ORANGE_BOOK —YNTRUE_DS
English description not available.
———
100358222033-11-15DS —YNTRUE_DS
English description not available.
———
100358222033-11-15ORANGE_BOOK —YNTRUE_DS
English description not available.
———
108758932033-11-15DS/U U-3540YNTRUE_DS
English description not available.
———
108758932033-11-15ORANGE_BOOK U-3540YNTRUE_DS
English description not available.
———
112928152033-11-15DS/DP/U U-3540YNTRUE_DS
English description not available.
———
112928152033-11-15ORANGE_BOOK U-3540YNTRUE_DS
English description not available.
———
125288362036-10-07U U-4394NYU
English description not available.
———
125288362036-10-07ORANGE_BOOK U-4394NYU
English description not available.
———
119039942037-02-22U U-3827NNU
English description not available.
———
119039942037-02-22U U-3826NNU
English description not available.
———
119039942037-02-22U U-3828NNU
English description not available.
———
119039942037-02-22ORANGE_BOOK U-3826;U-3827;U-3828NNU
English description not available.
———
124586952038-12-14DP —NNDP
English description not available.
———
124586952038-12-14ORANGE_BOOK —NNDP
English description not available.
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
NP2023-02-172026-02-22English description not available.YY2026-02-22—Source
NP2023-02-172026-02-22English description not available.YY2026-02-22
NCE
Full coverage date: 2026-02-22
Source
NCE2021-05-142026-05-14English description not available.YY2026-05-14—Source
NCE2021-05-142026-05-14English description not available.YY2026-05-14
NCE
Full coverage date: 2026-05-14
Source

2026-10-10 · CURRENT_SOURCE_RECORDS_FOUND · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Decision evidence (16)
TypeDateRoleBasisSource
PATENT2026-10-25HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2027-04-07HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2027-11-18HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2027-12-04HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2027-12-04HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2033-01-13HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2033-08-02HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2033-11-15HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2033-11-15HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2033-11-15HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2036-10-07CANONICAL_ANCHOREnglish description not available.Source
PATENT2037-02-22FTO_TAILEnglish description not available.Source
PATENT2038-12-14FTO_TAILEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_STATUS2036-10-07CANONICAL_DECISIONEnglish description not available.Source
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.